Clinical Trials
6 trialsNCT01622764 2024-05-06
89Zr-RO5323441 PET Imaging in Glioblastoma
University Medical Center Groningen
Phase 2 Withdrawn
NCT00702494 2022-03-16
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
BioInvent International AB
Phase 1 Completed
NCT02748135 2021-01-13
A Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma
Oncurious NV
Phase 1 Completed
NCT01148758 2016-11-02
A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer
Hoffmann-La Roche
Phase 1 Completed
NCT01308684 2016-11-02
A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma
Hoffmann-La Roche
Phase 1 Completed
NCT01308723 2016-11-02
A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma
Hoffmann-La Roche
Phase 1 Completed